Press release
Global Pharmacogenomics Market SWOT Analysis, Key Indicators, Forecast 2027 : Dynamic DNA Laboratories, Abbott Laboratories, Empire Genomics
PharmacogenomicsThe research report titled “Global Pharmacogenomics Market Set for Rapid Growth, to reach Value USD 10,492.2 million by 2025” and published by “Zion Market Research” is an in-depth and dedicated scrutiny of the existing stats of the global Pharmacogenomics market entailing the numerous facets pertinent to statistics and growth of the business. The report segregated into diverse sections to simplify the comprehension of the included data and thus, market dynamics. It encompasses all the major competitors and players Dynamic DNA Laboratories, Abbott Laboratories, Empire Genomics, LLC, Illumina, Inc., F. Hoffmann-La Roche Ltd., Myriad Genetics Inc., OneOme LLC, Thermo Fisher Scientific, Inc., and OPKO Health, Inc. among others.. involved in the global Pharmacogenomics market along with the various features relating to the market players like company profiles, supply chain value, product specifications, market shares, and so on. Also, the report entails the major strategic market developments, comprising R&D activities, collaborations, new product launch, agreements, joint ventures, partnerships, M&A, and presence & expansion extent of these prominent players on the global and regional scale. In addition, it comprises the systematic examination of business strategies for expansion of the prominent Pharmacogenomics market players.
Free | Sample copy of the report @ https://www.zionmarketresearch.com/sample/pharmacogenomics-market
The major players in the market include :
Dynamic DNA Laboratories, Abbott Laboratories, Empire Genomics, LLC, Illumina, Inc., F. Hoffmann-La Roche Ltd., Myriad Genetics Inc., OneOme LLC, Thermo Fisher Scientific, Inc., and OPKO Health, Inc. among others.
The Pharmacogenomics market report encompasses the general idea of the global Pharmacogenomics market including definition, classifications, and applications. Further, it includes the all-inclusive comprehension of several factors such as drivers, constraints, and major micro markets. The report is a wide-ranging source of widespread facts and figures for business strategists as it offers the historical &futuristic data such as demand & supply data, cost, revenue, profit, supply chain value, and so on. Furthermore, it entails the key market features, comprising production, revenue, price, capacity, gross margin, market share, consumption, gross, production rate, demand/supply, cost, capacity utilization rate, export/import, and CAGR (compound annual growth rate). In addition the report encompasses global Pharmacogenomics market segmentation on the basis of diverse facets like product/service type, application, technology, end-users, and major geographic regions North America, Europe, Asia-Pacific and Latin America. Apart from this, the researcher market analyst and experts present their outlook or insights of product sales, market share, and value along with the possible opportunities to grow or tap into in these regions.
Promising Regions & Countries Mentioned In The Pharmacogenomics Report:
North America ( United States)
Europe ( Germany, France, UK)
Asia-Pacific ( China, Japan, India)
Latin America ( Brazil)
The Middle East & Africa
Download Free PDF Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/pharmacogenomics-market
The Pharmacogenomics market report also entails the vigorous evaluation about the growth plot and all opportunities &risk related to of global Pharmacogenomics market during the forecast period. In addition, the report comprises the key events and most recent innovations in the industry together with the prospective trends technological progresses within the global Pharmacogenomics market that can impact its expansion graph. Entailing the pivotal data on the market’s statistics and dynamics, the report will serve as a valued asset in term of decision-making and guidance for the businesses and companies already active within industry or looking forward to enter into it.
Some Major Points in TOC Covered :
Chapter 1. Report Overview
Chapter 2. Global Growth Trends
Chapter 3. Market Share by Key Players
Chapter 4. Breakdown Data by Type and Application
Chapter 5. Market by End Users/Application
Chapter 6. COVID-19 Outbreak: Pharmacogenomics Market Industry Impact
Chapter 7. Opportunity Analysis in Covid-19 Crisis
Chapter 9. Market Driving Force
Reason to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharmacogenomics
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Pharmacogenomics, thereby allowing players to develop effective long term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
Inquire Clicking Here @ https://www.zionmarketresearch.com/inquiry/pharmacogenomics-market
Also, Research Report Examines:
Competitive companies and manufacturers in global market
By Product Type, Applications & Growth Factors
Industry Status and Outlook for Major Applications / End Users / Usage Area
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
244 Fifth Avenue, Suite N202
New York, 10001, United States
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pharmacogenomics Market SWOT Analysis, Key Indicators, Forecast 2027 : Dynamic DNA Laboratories, Abbott Laboratories, Empire Genomics here
News-ID: 2361993 • Views: …
More Releases from Zion Market Research

Distributed Energy Resource Management System (DERMS) Market Size to Reach USD 3 …
The global Distributed Energy Resource Management System (DERMS) market was valued at USD 615.24 Million in 2024 and is projected to reach USD 3,445.16 Million by 2034, growing at a remarkable CAGR of 18.8% between 2025 and 2034. The rapid integration of renewable energy, grid modernization initiatives, and supportive government policies are fueling the demand for advanced DERMS solutions worldwide.
A DERMS enables utilities and grid operators to efficiently manage distributed…

Video Surveillance As A Service (VSaaS) Market Size Worth USD 20.15 Billion by 2 …
The global video surveillance as a service (VSaaS) market was valued at USD 5.02 Billion in 2024 and is projected to reach USD 20.15 Billion by 2034, expanding at a CAGR of 14.9% between 2025 and 2034. With enterprises, governments, and households embracing cloud-based security, VSaaS has emerged as a transformative technology in global surveillance infrastructure. It provides cost-effective, scalable, and remotely accessible video monitoring, making it an attractive choice…

Automotive Engine Cooling System Market Size Worth USD 57.30 Billion by 2034, Gr …
The global automotive engine cooling system market was valued at USD 35.85 Billion in 2024 and is expected to reach USD 57.30 Billion by 2034, expanding at a CAGR of 4.8% between 2025 and 2034. Engine cooling systems play a vital role in maintaining engine temperature, ensuring efficiency, and enhancing vehicle performance. With the rise of electric vehicles (EVs), demand for advanced cooling solutions is expanding rapidly, creating new opportunities…

Wearable Technology Market to Surpass USD 365.32 Billion by 2034, Driven by Smar …
The global wearable technology market was valued at USD 89.26 billion in 2024 and is projected to reach USD 365.32 billion by 2034, growing at a CAGR of 13.8% between 2025 and 2034. The market growth is being fueled by rising consumer health consciousness, the popularity of fitness tracking devices, advancements in sensor technologies, and the integration of wearables into healthcare and consumer electronics ecosystems.
Wearable Technology Market Overview
Wearable technology refers…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…